Cargando…

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis

The prostacyclin analogue iloprost is used to treat vascular alterations and digital ulcers, the early derangements manifesting in systemic sclerosis (SSc), an autoimmune disease leading to skin and organ fibrosis. Bioindicator(s) of SSc onset and progress are still lacking and the therapeutic appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colasanti, Tania, Stefanantoni, Katia, Fantini, Cristina, Corinaldesi, Clarissa, Vasile, Massimiliano, Marampon, Francesco, Di Luigi, Luigi, Antinozzi, Cristina, Sgrò, Paolo, Lenzi, Andrea, Riccieri, Valeria, Crescioli, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456348/ https://www.ncbi.nlm.nih.gov/pubmed/36077548 http://dx.doi.org/10.3390/ijms231710150

Ejemplares similares

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
por: Corinaldesi, Clarissa, et al.
Publicado: (2021)

Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
por: Antinozzi, Cristina, et al.
Publicado: (2021)

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice
por: Zhu, Yuanjue, et al.
Publicado: (2010)

Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells
por: Antinozzi, C., et al.
Publicado: (2017)

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
por: Di Luigi, Luigi, et al.
Publicado: (2016)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

Vitamin D as a Shield against Aging
por: Fantini, Cristina, et al.
Publicado: (2023)

The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies
por: Di Luigi, Luigi, et al.
Publicado: (2013)

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
por: Palazzo, Raffaella, et al.
Publicado: (2022)

Advantages of Phosphodiesterase Type 5 Inhibitors in the Management of Glucose Metabolism Disorders: A Clinical and Translational Issue
por: Antinozzi, Cristina, et al.
Publicado: (2020)

CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
por: Pietraforte, Immacolata, et al.
Publicado: (2022)

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013)

Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives
por: Greco, Emanuela Alessandra, et al.
Publicado: (2022)

The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
por: Giannattasio, S., et al.
Publicado: (2018)

Systemic Response of Antioxidants, Heat Shock Proteins, and Inflammatory Biomarkers to Short-Lasting Exercise Training in Healthy Male Subjects
por: Dimauro, Ivan, et al.
Publicado: (2021)

The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
por: Di Luigi, Luigi, et al.
Publicado: (2020)

Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
por: Lande, Roberto, et al.
Publicado: (2020)

IP receptor-dependent activation of PPARγ by stable prostacyclin analogues
por: Falcetti, Emilia, et al.
Publicado: (2007)

Effect of Tadalafil Administration on Redox Homeostasis and Polyamine Levels in Healthy Men with High Level of Physical Activity
por: Duranti, Guglielmo, et al.
Publicado: (2021)

Effective prevention of pseudothrombocytopenia in feline blood samples with the prostaglandin I(2) analogue Iloprost
por: Riond, Barbara, et al.
Publicado: (2015)

Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF β-Smad Signal Pathway
por: Chen, Yun, et al.
Publicado: (2014)

Sildenafil Reduces Expression and Release of IL-6 and IL-8 Induced by Reactive Oxygen Species in Systemic Sclerosis Fibroblasts
por: Di Luigi, Luigi, et al.
Publicado: (2020)

Exploratory Analysis in the Differences in Blood Serum and Seminal Plasma of Adipose-Tissue Related Peptides in Obese and Non-Obese Men and Their Correlations With Semen Parameters
por: Antinozzi, Cristina, et al.
Publicado: (2021)

Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
por: Yajima, Shin, et al.
Publicado: (2019)

Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
por: Rogula, Sylwester P., et al.
Publicado: (2020)

Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications
por: Corinaldesi, C., et al.
Publicado: (2015)

Hydrogen Peroxide Stimulates Dihydrotestosterone Release in C2C12 Myotubes: A New Perspective for Exercise-Related Muscle Steroidogenesis?
por: Antinozzi, Cristina, et al.
Publicado: (2022)

Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature
por: Magnani, Luca, et al.
Publicado: (2023)

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Magnan, Marie-Anne, et al.
Publicado: (2021)

Right ventricular function mirrors clinical improvement with use of prostacyclin analogues in pediatric pulmonary hypertension
por: Hopper, Rachel K., et al.
Publicado: (2018)

Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2021)

User preference for a portable syringe pump for iloprost infusion
por: Laria, Antonella, et al.
Publicado: (2015)

PROSTACYCLIN IN HEALTH AND DISEASE
Publicado: (1983)

Prostacyclin: An Inflammatory Paradox
por: Stitham, Jeremiah, et al.
Publicado: (2011)

COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort
por: Pellegrino, Greta, et al.
Publicado: (2020)

New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
por: Lande, Roberto, et al.
Publicado: (2021)

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

Iloprost for COVID-19-related vasculopathy
por: Moezinia, Carine J, et al.
Publicado: (2020)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
por: Blitek, Agnieszka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vevr1eb64jn7c9i4sog56jskn6